Sequenta's Corporate Minority Round

Sequenta raised a round of funding on October 20, 2014. Investors include Celgene.

Sequenta, formerly MLC Dx, is a biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical diagnostics. Sequ…

Articles about Sequenta's Corporate Minority Round: